CD1C and Burkitt lymphoma: Increased NK cell cytotoxicity in vitro against Burkitt lymphoma cells was also achieved by co-culturing human NK cells together with TLR-activated CD1c+ myeloid and plasmacytoid DCs together instead of culturing them with only one specific DC subset alone (96).